Life Sciences Forum

The Sizzling Science and Business of Immuno-Oncology

What is the immuno-oncology revolution that’s sweeping the world of cancer treatments? How is it impacting every aspect of cancer treatment development for companies (small and large), clinicians, payers and patients?

Come hear from panelists who are living at the pioneering intersection of science and business of immuno-oncology. Ask your tough questions about the field and its potential to provide cures to certain cancers. 

Panelists:

  • Mark Velleca, MD, Ph.D., chief executive officer, G1 Therapeutics 
  • Smita Nair, Ph.D., associate professor of surgery, Duke University School of Medicine, director of immunotherapy sciences focus group, Duke Cancer Institute
  • Taylor Schreiber, M.D., Ph.D., chief scientific officer, Heat Biologics
  • Bruce McCreedy, Ph.D., senior vice president cell therapy, Precision BioSciences

​Moderator:

  • Anil Goyal, Ph.D., CLP, managing director, OpenDoors Group, vp of business development at Esanex, Inc and MimiVax, LLC

Presented by NC COIN and NCBiotech Center              

Agenda

4 p.m. - Registration

4:30 p.m. - Program

6 p.m. - Reception and networking

 

 

Directions/Parking

For directions visit here

Lead Sponsors:

   

      

Registration

Tickets are $25 advance/$30 on-site

 

 

Date
-
Address

North Carolina Biotechnology Center

Cost
$25 advance/$30 on-site
scroll back to top of page